Canada· CA-DIN-02247600
BOOSTRIX
A other bacterial vaccines product containing diphtheria toxoid + pertussis toxoid + pertactin + filamentous haemagglutinin, registered in Canada by GLAXOSMITHKLINE INC. The same ATC class is registered in 3 of our 19 countries.
Checked against Health Canada Drug Product Database (Canada) on
Informational only — not a medical device.
Where it is registered
Diphtheria toxoid + pertussis toxoid + pertactin + filamentous haemagglutinin is registered in 3 of 19 countries.
Countries holding a registration under ATC J07AX (other bacterial vaccines), each read from that country’s own register.
- This record: Canada, from Health Canada Drug Product Database (Canada)
- 2 of them publish a price we can compare per daily dose
Diphtheria toxoid + pertussis toxoid + pertactin + filamentous haemagglutinin · ATC J07AX
3 / 19 countries
- Belgiumprice
- Canada
- Polandprice
The record
At a glance
Health Canada Drug Product Database (Canada)- Active substance
- DIPHTHERIA TOXOID + PERTUSSIS TOXOID + PERTACTIN + FILAMENTOUS HAEMAGGLUTININ
- Manufacturer
- GLAXOSMITHKLINE INC
- Country
- Canada (CA)
- ATC code
- J07AX
- ATC class
- Other bacterial vaccines
- Reimbursed
- Not published by this register
- Source register
- Health Canada Drug Product Database (Canada)
- Last checked
- October 1, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under J07AX
Other bacterial vaccines, as other registers publish it.
- BelgiumBroncho-Vaxom Adultes 7 mgImpexeco
- BelgiumBroncho-Vaxom Enfants 3,5 mgImpexeco
- BelgiumBroncho-Vaxom Kinderen 3.5 mgPI Pharma
- BelgiumBroncho-Vaxom Volwassenen 7 mgAbacus Medicine
- BelgiumBroncho-Vaxom Volwassenen 7 mgPI Pharma
- BelgiumBuccalinDesma
- PolandIsmigenLallemand Pharma Europe
- PolandPolyvaccinum forte Nieswoista szczepionka bakteryjnaInstytut Biotechnologii Surowic i Szczepionek BIOMED S.A.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e16bf3d8-91ac-492e-a3a1-e8ecb3f468ca GET /v1/drugs/e16bf3d8-91ac-492e-a3a1-e8ecb3f468ca?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"din": "02247600",
"form": "SUSPENSION",
"class": "Human",
"routes": [
"INTRAMUSCULAR"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "J07AX",
"schedule": [
"Schedule D"
],
"drug_code": "71860",
"strengths": [
"2 UNIT",
"8 MCG",
"2.5 MCG",
"20 UNIT"
],
"ahfs_class": null,
"substances": [
"DIPHTHERIA TOXOID",
"PERTUSSIS TOXOID",
"PERTACTIN",
"FILAMENTOUS HAEMAGGLUTININ",
"TETANUS TOXOID"
],
"product_categorization": null
}See everything about diphtheria toxoid + pertussis toxoid + pertactin + filamentous haemagglutinin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.